Skip to Content
Watertown Bio
Home
Newsletter
Community Overview
Organization Gallery
Therapeutic Pipeline Overview
Industry Reports
About
Contact
Support Us
(0)
Cart (0)
Support Watertown Bio
Watertown Bio
Home
Newsletter
Community Overview
Organization Gallery
Therapeutic Pipeline Overview
Industry Reports
About
Contact
Support Us
(0)
Cart (0)
Support Watertown Bio
Home
Newsletter
Folder: Life Science Community Info
Back
Community Overview
Organization Gallery
Therapeutic Pipeline Overview
Industry Reports
Folder: About Us
Back
About
Contact
Support Us
Support Watertown Bio
Kestrel's $1.45 billion AbbVie Deal, FDA Approves First Ever PROTAC, and Werewolf Breaks Arsenal Lease.
News Roundup Sam Ghilardi 5/12/26 News Roundup Sam Ghilardi 5/12/26

Kestrel's $1.45 billion AbbVie Deal, FDA Approves First Ever PROTAC, and Werewolf Breaks Arsenal Lease.

Plus more details on Windgap's big pharma partnership and a number of people moves.

Read More
ALS TDI moves to Arsenal Yards, Windgap Medical’s Big Pharma Collab, and Watertown’s Q1 fundraising numbers
News Roundup Sam Ghilardi 4/28/26 News Roundup Sam Ghilardi 4/28/26

ALS TDI moves to Arsenal Yards, Windgap Medical’s Big Pharma Collab, and Watertown’s Q1 fundraising numbers

Plus the initial dosing of Enanta Plus Addgene’s rebrand and Earth Day clean upsAvencell's Clinical Trials

Read More
An FDA Rejection, A Big Pharma Purchase, and Charting Watertown's Life Science Future -Watertown Bio News RoundUp
News Roundup Sam Ghilardi 2/17/26 News Roundup Sam Ghilardi 2/17/26

An FDA Rejection, A Big Pharma Purchase, and Charting Watertown's Life Science Future -Watertown Bio News RoundUp

Plus another $10 million in VC raised, Souffle inks a partnership with Bayer, and more

Read More

Watertown Bio

Contact

info@watertown.bio